Kawasaki disease in older children and young adults: 10 years of experience in Marseille, France;Maladie de Kawasaki chez le grand enfantet l'adulte jeune: expérience marseillaisesur 10 ans

Archives de Pediatrie

Volumn 18, Issue 7, 2011, Pages 731-736

  Bresson, V ^a   Bonello, B ^a   Rousset Rouviere C ^a   Serratrice, J ^a   Chabrol, B ^a   Dubus, J C ^a,b   Bosdure, E ^a  

^a TIMONE HOSPITAL   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; CLINICAL FEATURE; DELAYED DIAGNOSIS; DISEASE PREDISPOSITION; FRANCE; HUMAN; MUCOCUTANEOUS LYMPH NODE SYNDROME; PROGNOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADMINISTRATION, ORAL; ADOLESCENT; ADRENAL CORTEX HORMONES; AGE FACTORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CHILD; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIAGNOSTIC ERRORS; FEMALE; FRANCE; HEART DISEASES; HOSPITALS, UNIVERSITY; HUMANS; IMMUNIZATION, PASSIVE; INFUSIONS, INTRAVENOUS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; SEX FACTORS; YOUNG ADULT;

EID: 79959237593     PISSN: 0929693X     EISSN: 1769664X     Source Type: Journal    
DOI: 10.1016/j.arcped.2011.04.014     Document Type: Article

References (31)

1. Newburger J.W., Takahashi M., Gerber M.A., et al. Diagnosis, treatment and long-term management of Kawasaki disease: a statement for health professionals from the Committee on rheumatic fever, endocarditis and kawasaki disease, Council on cardiovascular disease in the Young American Heart Association. Circulation 2004, 110:2747-2771.
2. Shulman S.T., Rowley A.H. Advances in Kawasaki disease. Eur J Pediatr 2004, 163:285-291.
3. Bronstein D.E., Dille A.M., Austin J.P., et al. Relationship of climate, ethnicity and socioeconomic status to Kawasaki disease in San Diego County, 1994 through 1998. Pediatr Infect Dis J 2000, 19:1087-1091.
4. Rozo J.C., Jefferies J.L., Eidem B.W., et al. Kawasaki disease in the adult: a case report and review of the literature. Tex Heart Inst J 2004, 31:160-164.
5. Nakaruna Y., Yashiro M., Uehara R., et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2007-2008 nationwide survey. J Epidemiol 2010, 20:302-307.
6. Stockheim J.A., Innocentini N., Shulman S.T. Kawasaki disease in older children and adolescents. J Pediatr 2000, 137:250-252.
7. Bader-Meunier B. Maladie de Kawasaki: attention aux formes atypiques. Med Enfance 2003, 6:343-347.
8. Galeotti C., Bayry J., Kone-Paut I., et al. Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin. Autoimmun Rev 2010, 9:441-448.
9. Tse S.M.L., Silverman E.D., McCrindle B.W., et al. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease. J Pediatr 2002, 140:450-455.
10. Ozen S., Rupperto N., Dillon M.J., et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006, 65:936-941.
11. Wood L.E., Tulloh R.M.R. Diagnosis and management of Kawasaki disease in children. Paediatr Child Health 2007, 18:70-74.
12. Yilmazer M.M., Mese T., Demirpence S., et al. Incomplete (atypical) Kawasaki disease in a young infant with remarkable paucity of signs. Rheumatol Int 2010, 30:991-992.
13. Cimaz R., Sundel R., Head M.D. Atypical and incomplete Kawasaki disease. Best Pract Res Clin Rheumatol 2009, 23:689-697.
14. Pannarai P.S., Turner C.L., Bastian J.F., et al. Failure to diagnose Kawasaki disease at the extremes of pediatric age range. Pediatr Infect Dis J 2004, 23:789-791.
15. Gomard-Mennesson E., Landron C., Dauphin C., et al. Kawasaki disease in adults: report of 10 cases. Medicine (Baltimore) 2010, 89:149-158.
16. Newburger J.W. Kawasaki disease: who is at risk?. J Pediatr 2000, 137:149-152.
17. Nomura Y., Arata M., Koriyama C., et al. A severe form of Kawasaki disease presenting with only fever and cervical lymphadenopathy at admission. J Pediatr 2010, 156:786-791.
18. Seve P., Bui-Xuan C., Charhon A., et al. Adult Kawasaki disease. Rev Med Interne 2003, 24:577-584.
19. Balasubramanian S., Ganesh R. Recurrent Kawasaki disease. Indian J Pediatr 2009, 76:848-849.
20. Belay E.D., Maddox R.A., Holman R.C., et al. Kawasaki syndrome and risk factors for coronary artery abnormalities. Pediatr Infect Dis J 2006, 25:245-249.
21. Duzova A., Topaloglu R., Keskin M., et al. An unusual pattern of arthritis in a child with Kawasaki disease. Clin Rheumatol 2004, 23:73-75.
22. Abushaban L., Salama A., Uthaman B., et al. Do we have a less severe form of Kawasaki disease or is it the gammaglobulin effect?. Int J Cardiol 1999, 69:71-76.
23. Muta H., Ishii M., Sakaue T., et al. Older age is a risk factor for the development of cardiovascular sequelae in Kawasaki disease. Pediatrics 2004, 114:751-754.
24. Pouchot J., Vinceneux P. Diagnostic, évolution et pronostic, pathogénie et traitement de la maladie de Still de l'adulte. Presse Med 2004, 33:1019-1025.
25. Bonany P.J., Bilkis M.D., Gallo G., et al. Acute renal failure in typical Kawasaki disease. Pediatr Nephrol 2002, 17:329-331.
26. Freeman A.F., Shulman S.T. Issues in the diagnosis of Kawasaki disease. Progress in Pediatr Cardiol 2004, 19:123-128.
27. Yanagawa H., Tuchong Z., Ojima T., et al. Effects of gamma-globulin on the cardiac sequelae of Kawasaki disease. Pediatr Cardiol 1999, 20:248-251.
28. Wright H., Waddington C., Geddes J., et al. Facial nerve palsy complicating Kawasaki disease. Pediatrics 2008, 122:e783-e785.
29. Momenah T., Sanatani S., Potts J., et al. Kawasaki disease in the older child. Pediatrics 1998, 102:e7.
30. Terai M., Shulman S.T. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma-globulin dose but independent of salicylate dose. J Pediatr 1997, 131:888-893.
31. Miura M., Ohki H., Tsuchihashi T., et al. Coronary risk factors in Kawasaki disease treated with additional gamma-globulin. Arch Dis Child 2004, 89:776-780.